Global Hospital Care Partnering 2015-2022: Key Deal Trends, Players and Financials

2022-07-12
PRNewswire
抗体
DUBLIN, July 12, 2022 /PRNewswire/ -- The "Global Hospital Care Partnering 2015-2022: Deal Trends, Players and Financials" report has been added to
ResearchAndMarkets.com's offering.
Global Hospital Care Partnering 2015 to 2022 provides the full collection of Hospital Care disease deals signed between the world's pharmaceutical and biotechnology companies since 2015.
Trends in Hospital Care partnering deals
Financial deal terms for headline, upfront and royalty by stage of development
Hospital Care partnering agreement structure
Hospital Care partnering contract documents
Top Hospital Care deals by value
Most active Hospital Care dealmakers
Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.
The report takes readers through the comprehensive Hospital Care disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Hospital Care deals.
The report presents financial deal terms values for Hospital Care deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.
Global Hospital Care Partnering 2015 to 2022 includes:
Trends in Hospital Care dealmaking in the biopharma industry since 2015
Access to headline, upfront, milestone and royalty data
Access to hundreds of Hospital Care deal contract documents
Comprehensive access to over 1200 Hospital Care deal records
The leading Hospital Care deals by value since 2015
Most active Hospital Care dealmakers since 2015
Key Topics Covered:
Chapter 1 - Introduction
Chapter 2 - Trends in Hospital Care dealmaking
2.1. Introduction
2.2. Hospital Care partnering over the years
2.3. Hospital Care partnering by deal type
2.4. Hospital Care partnering by industry sector
2.5. Hospital Care partnering by stage of development
2.6. Hospital Care partnering by technology type
2.7. Hospital Care partnering by therapeutic indication
Chapter 3 -Financial deal terms for Hospital Care partnering
3.1. Introduction
3.2. Disclosed financials terms for Hospital Care partnering
3.3. Hospital Care partnering headline values
3.4. Hospital Care deal upfront payments
3.5. Hospital Care deal milestone payments
3.6. Hospital Care royalty rates
Chapter 4 - Leading Hospital Care deals and dealmakers
4.1. Introduction
4.2. Most active in Hospital Care partnering
4.3. List of most active dealmakers in Hospital Care
4.4. Top Hospital Care deals by value
Chapter 5 - Hospital Care contract document directory
5.1. Introduction
5.2. Hospital Care partnering deals where contract document available
Chapter 6 - Hospital Care dealmaking by therapeutic target
6.1. Introduction
6.2. Deals by Hospital Care therapeutic target
Companies Mentioned
3M
3SBio
111
Acare Medical Science
Accelus
AccuTec Blades
Acelity
Acell
Acentrus Specialty
ActLight
AdaptHealth
ADAS 3D Medical
Adeor Medical
Adhezion Biomedical
Advanced Cooling Therapy
Aerapy
Aesthetic Management Partners
Agadia Systems
Agiliti
Aguettant
Aidoc
Aitrics
Algeos
ALK-Abello
Allergan
Allergan Aesthetics
Allied Centre for Medical Excellence
Alliqua Biomedical
Alloksys Life Sciences
Almirall
Alphamedix
Altitude International
Alvarado Hospital Medical Center
Alyzen Medical Physics
Ambra Health
Ambu
Amedisys
American Society for Aesthetic Plastic Surgery
American Well
Amerinet
AMNIOX
Amplifire
Ancestry
Anelto
Angiodynamics
Anita Tecnica
Anthem
Apex Physics Partners
Applied DNA Sciences
Applimotion
APR Medtech
Archer Capital
argenx
Argon Medical Devices
Aridea Solutions
Arkansas Childrens Hospital
Armaghan Salamat Kish
Armor
Artegraft
Arthrex
Asahi Kasei
Ascendum
Ascension
Ascension Saint Thomas
Asensus Surgical
ASICO
Aspen Surgical Products
Assure
Asys
Athersys
Atlas Lift Tech
Atnahs Pharma
Atricure
For more information about this report visit https://www.researchandmarkets.com/r/lcutzo
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
机构
适应症
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。